These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36271955)

  • 101. Binaural hearing in monaural conductive or mixed hearing loss fitted with unilateral Bonebridge.
    Canale A; Urbanelli A; Albera R; Gragnano M; Bordino V; Riva G; Sportoletti Baduel E; Albera A
    Acta Otorhinolaryngol Ital; 2024 Apr; 44(2):113-119. PubMed ID: 38651553
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Results of a 2-Year Prospective Multicenter Study Evaluating Long-term Audiological and Clinical Outcomes of a Transcutaneous Implant for Bone Conduction Hearing.
    Kruyt IJ; Monksfield P; Skarzynski PH; Green K; Runge C; Bosman A; Blechert JI; Wigren S; Mylanus EAM; Hol MKS
    Otol Neurotol; 2020 Aug; 41(7):901-911. PubMed ID: 32310837
    [TBL] [Abstract][Full Text] [Related]  

  • 103. The bone conduction implant: Clinical results of the first six patients.
    Reinfeldt S; Håkansson B; Taghavi H; Fredén Jansson KJ; Eeg-Olofsson M
    Int J Audiol; 2015 Jun; 54(6):408-16. PubMed ID: 25705995
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Indication criteria and outcomes with the Bonebridge transcutaneous bone-conduction implant.
    Riss D; Arnoldner C; Baumgartner WD; Blineder M; Flak S; Bachner A; Gstoettner W; Hamzavi JS
    Laryngoscope; 2014 Dec; 124(12):2802-6. PubMed ID: 25142577
    [TBL] [Abstract][Full Text] [Related]  

  • 105. The Merits of Bilateral Application of Middle Ear Implants in Patients With Bilateral Conductive and/or Mixed Hearing Loss.
    Agterberg MJH; Straatman L; Bruchhage KL; Jürgens T; Hollfelder D; Leichtle A
    Trends Hear; 2024; 28():23312165241264466. PubMed ID: 39106413
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Beyond the surface: exploring contributing factors to bone anchored hearing implant complications.
    Zammit M; Chandrasekar B; Sweed A; Attlmayr B
    Eur Arch Otorhinolaryngol; 2024 Oct; 281(10):5535-5540. PubMed ID: 39126510
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Artefacts on magnetic resonance imaging with Osia®2 bone conduction hearing aid: A cadaver study.
    Diosi B; Bere Z; Csomor A; Tapai T; Toth Z; Kovacs E; Posta B; Csanady M; Nogradi A; Kincses ZT; Rovo L; Perenyi A
    Cochlear Implants Int; 2024 Oct; ():1-11. PubMed ID: 39400104
    [TBL] [Abstract][Full Text] [Related]  

  • 108. The impact of the Cochlear™ Osia
    Park KS; Kim HC; Lee S; Cho HH
    Sci Prog; 2024; 107(3):368504241280252. PubMed ID: 39262399
    [TBL] [Abstract][Full Text] [Related]  

  • 109. A Rare Case of Osia Extrusion. Our Management Proposal.
    Malagutti N; Musumano LB; Migliorelli A; Borin M
    Indian J Otolaryngol Head Neck Surg; 2024 Aug; 76(4):3641-3643. PubMed ID: 39130322
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Long-term data of the new transcutaneous partially implantable bone conduction hearing system Osia®.
    Rauch AK; Wesarg T; Aschendorff A; Speck I; Arndt S
    Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4279-4288. PubMed ID: 34792628
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Prediction of postoperative speech comprehension with the transcutaneous partially implantable bone conduction hearing system Osia®.
    Arndt S; Wesarg T; Aschendorff A; Speck I; Hocke T; Jakob TF; Rauch AK
    HNO; 2024 Jan; 72(Suppl 1):1-9. PubMed ID: 37812258
    [TBL] [Abstract][Full Text] [Related]  

  • 112. A New Active Osseointegrated Implant System in Patients with Single-Sided Deafness.
    Willenborg K; Avallone E; Maier H; Lenarz T; Busch S
    Audiol Neurootol; 2022; 27(1):83-92. PubMed ID: 33902037
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Multicentric study on surgical information and early safety and performance results with the Bonebridge BCI 602: an active transcutaneous bone conduction hearing implant.
    Sprinzl G; Toner J; Koitschev A; Berger N; Keintzel T; Rasse T; Baumgartner WD; Honeder C; Magele A; Plontke S; Götze G; Schmutzhard J; Zelger P; Corkill S; Lenarz T; Salcher R
    Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1565-1579. PubMed ID: 36625869
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Early Outcomes of a New Active Transcutaneous Bone Conduction Implant in Pediatric Patients.
    You P; Choi A; Drob J; Hunsaker SM; Liu YC; Silva R
    Otol Neurotol; 2022 Feb; 43(2):212-218. PubMed ID: 34855683
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Active transcutaneous bone-anchored hearing implant: how I do it.
    Arndt S; Rauch AK; Speck I
    Eur Arch Otorhinolaryngol; 2021 Oct; 278(10):4119-4122. PubMed ID: 34155570
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Early Osia® 2 bone conduction hearing implant experience: Nationwide controlled-market release data and single-center outcomes.
    Goldstein MR; Bourn S; Jacob A
    Am J Otolaryngol; 2021; 42(1):102818. PubMed ID: 33166860
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Multicenter Clinical Investigation of a New Active Osseointegrated Steady-State Implant System.
    Mylanus EAM; Hua H; Wigren S; Arndt S; Skarzynski PH; Telian SA; Briggs RJS
    Otol Neurotol; 2020 Oct; 41(9):1249-1257. PubMed ID: 32925852
    [TBL] [Abstract][Full Text] [Related]  

  • 118. How I do it: Cochlear Osia 2 System surgery placement.
    Soloperto D; Dallari V; Molteni G
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):929-933. PubMed ID: 36271955
    [TBL] [Abstract][Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 6.